Propylamphetamine
From Wikipedia, the free encyclopedia
|
Propylamphetamine
|
|
| Systematic (IUPAC) name | |
| N-propyl-1-phenyl-propan-2-amine | |
| Identifiers | |
| CAS number | |
| ATC code | ? |
| PubChem | |
| Chemical data | |
| Formula | C12H19N |
| Mol. mass | 177.286 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | hepatic |
| Half life | ? |
| Excretion | renal |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
N-propylamphetamine is a stimulant drug derived from amphetamine which was invented in the 1970s.
Propylamphetamine was used mainly for research into the metabolism of amphetamines,[1] and as a reference compound to compare to other amphetamines,[2] but animal research has shown it to be an active stimulant slightly less potent than amphetamine.[3]
[edit] References
- ^ Nazarali AJ, Baker GB, Coutts RT, Pasutto FM. Amphetamine in rat brain after intraperitoneal injection of N-alkylated analogues. Progress in Neuropsychopharmacology and Biological Psychiatry. 1983;7(4-6):813-6.
- ^ Valtier S, Cody JT. Evaluation of internal standards for the analysis of amphetamine and methamphetamine. Journal of Analytical Toxicology. 1995 Oct;19(6):375-80.
- ^ Woolverton WL, Shybut G, Johanson CE. Structure-activity relationships among some d-N-alkylated amphetamines. Pharmacology Biochemistry and Behavior. 1980 Dec;13(6):869-76.
|
|||||

